Insider Trading History of Klee Justin B.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Klee Justin B. since 2022. This trader's CIK number is 1898314. At the time of last reporting, Klee Justin B. was the Co-Chief Executive Officer of Amylyx Pharmaceuticals, Inc.. (stock ticker symbol AMLX). Also see all insider trading activities at Amylyx Pharmaceuticals, Inc..


Yearly summary of insider trading at Amylyx Pharmaceuticals, Inc. (AMLX) by Klee Justin B.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 AMLX 0 $0 40,816 $145,768 36,310 $57,006
2024 AMLX 0 $0 28,565 $232,240 63,690 $99,993
2023 AMLX 0 $0 105,968 $3,433,238 0 $0
2022 AMLX 0 $0 0 $0 334,520 $123,772


Insider trading of Amylyx Pharmaceuticals, Inc. (AMLX) by Klee Justin B.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-03-31 AMLX Sale 21,490 3.46 74,462
2025-02-05 AMLX Option Ex 36,310 1.57 57,006
2025-02-03 AMLX Sale 11,855 3.47 41,101
2025-01-06 AMLX Sale 7,471 4.04 30,205
2024-11-04 AMLX Option Ex 63,690 1.57 99,993
2024-09-30 AMLX Sale 18,589 3.20 59,429
2024-03-05 AMLX Sale 4,135 18.73 77,440
2024-01-09 AMLX Sale 5,841 16.33 95,371
2023-03-16 AMLX Sale 100,000 32.16 3,215,800
2023-01-06 AMLX Sale 5,968 36.43 217,438
2022-05-05 AMLX Option Ex 334,520 .37 123,772

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Klee Justin B. (Co-Chief Executive Officer of Amylyx Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.